| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0061 | 0.9 |